Additionally, THP-1.SIRP-ß2 also potentiated phagocytosis of carcinoma cell lines DLD-1 and OVCAR-3 compared to THP-1.EV upon treatment with EGFR-antibody cetuximab (CTX) (Figure 2I). The gene discussed is EGFR; the disease is carcinoma.